Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary

  Neoplasms of the CNS

  Free Subscription


2 Acta Neuropathol
1 BMC Cancer
1 Br J Cancer
1 Childs Nerv Syst
2 Clin Cancer Res
1 J Neurol
1 J Neurooncol
1 J Neuropathol Exp Neurol
2 J Neurosurg
1 Nat Rev Cancer
1 Neuro Oncol
1 Neurology
1 Neuroradiology
2 Neurosurgery
1 Oncogene
1 Pediatr Hematol Oncol
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Acta Neuropathol

  1. CHIANG J, Li X, Liu APY, Qaddoumi I, et al
    Tectal glioma harbors high rates of KRAS G12R and concomitant KRAS and BRAF alterations.
    Acta Neuropathol. 2019 Dec 10. pii: 10.1007/s00401-019-02112.
    PubMed     Text format    

  2. LI BK, Vasiljevic A, Dufour C, Yao F, et al
    Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study.
    Acta Neuropathol. 2019 Dec 9. pii: 10.1007/s00401-019-02111.
    PubMed     Text format     Abstract available

    BMC Cancer

  3. GANGEMI V, Mignogna C, Guzzi G, Lavano A, et al
    Impact of [(64)Cu][Cu(ATSM)] PET/CT in the evaluation of hypoxia in a patient with Glioblastoma: a case report.
    BMC Cancer. 2019;19:1197.
    PubMed     Text format     Abstract available

    Br J Cancer

  4. BJORKBLOM B, Jonsson P, Tabatabaei P, Bergstrom P, et al
    Metabolic response patterns in brain microdialysis fluids and serum during interstitial cisplatin treatment of high-grade glioma.
    Br J Cancer. 2019 Dec 10. pii: 10.1038/s41416-019-0652.
    PubMed     Text format     Abstract available

    Childs Nerv Syst

  5. CORTI C, Urgesi C, Massimino M, Gandola L, et al
    Effects of supratentorial and infratentorial tumor location on cognitive functioning of children with brain tumor.
    Childs Nerv Syst. 2019 Dec 12. pii: 10.1007/s00381-019-04434.
    PubMed     Text format     Abstract available

    Clin Cancer Res

  6. ZHANG DY, Dmello C, Chen L, Arrieta VA, et al
    Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations.
    Clin Cancer Res. 2019 Dec 12. pii: 1078-0432.CCR-19-2182.
    PubMed     Text format     Abstract available

  7. HARGRAVE DR, Bouffet E, Tabori U, Broniscer A, et al
    Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study.
    Clin Cancer Res. 2019 Dec 6. pii: 1078-0432.CCR-19-2177.
    PubMed     Text format     Abstract available

    J Neurol

  8. WANG FX, Chen K, Huang FQ, Alolga RN, et al
    Cerebrospinal fluid-based metabolomics to characterize different types of brain tumors.
    J Neurol. 2019 Dec 10. pii: 10.1007/s00415-019-09665.
    PubMed     Text format     Abstract available

    J Neurooncol

  9. SCHAFF LR, Yan D, Thyparambil S, Tian Y, et al
    Characterization of MGMT and EGFR protein expression in glioblastoma and association with survival.
    J Neurooncol. 2019 Dec 10. pii: 10.1007/s11060-019-03358.
    PubMed     Text format     Abstract available

    J Neuropathol Exp Neurol

  10. MARTIN AM, Bell WR, Yuan M, Harris L, et al
    PD-L1 Expression in Pediatric Low-Grade Gliomas Is Independent of BRAF V600E Mutational Status.
    J Neuropathol Exp Neurol. 2019 Dec 9. pii: 5670883. doi: 10.1093.
    PubMed     Text format     Abstract available

    J Neurosurg

  11. ARRIETA VA, Iwamoto F, Lukas RV, Sachdev S, et al
    Can patient selection and neoadjuvant administration resuscitate PD-1 inhibitors for glioblastoma?
    J Neurosurg. 2019 Dec 6:1-6. doi: 10.3171/2019.9.JNS192523.
    PubMed     Text format    

  12. RUSTEMI O, Raneri F, Beggio G, Volpin L, et al
    Letter to the Editor. Cost-effectiveness of sodium fluorescein in high-grade gliomas.
    J Neurosurg. 2019 Dec 13:1-2. doi: 10.3171/2019.10.JNS192817.
    PubMed     Text format    

    Nat Rev Cancer

  13. HOVESTADT V, Ayrault O, Swartling FJ, Robinson GW, et al
    Medulloblastomics revisited: biological and clinical insights from thousands of patients.
    Nat Rev Cancer. 2019 Dec 9. pii: 10.1038/s41568-019-0223.
    PubMed     Text format     Abstract available

    Neuro Oncol

  14. APPAY R, Dehais C, Maurage CA, Alentorn A, et al
    CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.
    Neuro Oncol. 2019 Jul 12. pii: 5531923. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. KEBIR S, Hattingen E, Niessen M, Rauschenbach L, et al
    Olfactory function as independent prognostic factor in glioblastoma.
    Neurology. 2019 Dec 12. pii: WNL.0000000000008744.
    PubMed     Text format     Abstract available


  16. PARK CJ, Choi YS, Park YW, Ahn SS, et al
    Diffusion tensor imaging radiomics in lower-grade glioma: improving subtyping of isocitrate dehydrogenase mutation status.
    Neuroradiology. 2019 Dec 9. pii: 10.1007/s00234-019-02312.
    PubMed     Text format     Abstract available


  17. NG S, Herbet G, Moritz-Gasser S, Duffau H, et al
    Return to Work Following Surgery for Incidental Diffuse Low-Grade Glioma: A Prospective Series With 74 Patients.
    Neurosurgery. 2019 Dec 9. pii: 5669999. doi: 10.1093.
    PubMed     Text format     Abstract available

  18. OHBA S, Murayama K, Kuwahara K, Pareira ES, et al
    The Correlation of Fluorescence of Protoporphyrinogen IX and Status of Isocitrate Dehydrogenase in Gliomas.
    Neurosurgery. 2019 Dec 13. pii: 5675407. doi: 10.1093.
    PubMed     Text format     Abstract available


  19. HERRMANN A, Lahtz C, Song J, Aftabizadeh M, et al
    Integrin alpha6 signaling induces STAT3-TET3-mediated hydroxymethylation of genes critical for maintenance of glioma stem cells.
    Oncogene. 2019 Dec 9. pii: 10.1038/s41388-019-1134.
    PubMed     Text format     Abstract available

    Pediatr Hematol Oncol

  20. PERLA AS, Fratini L, Cardoso PS, de Farias CB, et al
    Fingolimod (FTY720) reduces viability and survival and increases histone H3 acetylation in medulloblastoma cells.
    Pediatr Hematol Oncol. 2019 Dec 11:1-6. doi: 10.1080/08880018.2019.1699213.
    PubMed     Text format     Abstract available

    PLoS One

  21. SCHULT T, Hauser TK, Klose U, Hurth H, et al
    Fiber visualization for preoperative glioma assessment: Tractography versus local connectivity mapping.
    PLoS One. 2019;14:e0226153.
    PubMed     Text format     Abstract available

  22. DATTA K, Lauritzen MH, Merchant M, Jang T, et al
    Reversed metabolic reprogramming as a measure of cancer treatment efficacy in rat C6 glioma model.
    PLoS One. 2019;14:e0225313.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.